- Home
- KLRS vs INTG Comparison
KLRS vs INTG Comparison
Compare KLRS & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- INTG
- Stock Information
- Founded
- KLRS 2019
- INTG 1965
- Country
- KLRS United States
- INTG United States
- Employees
- KLRS N/A
- INTG N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- INTG Building operators
- Sector
- KLRS Health Care
- INTG Real Estate
- Exchange
- KLRS Nasdaq
- INTG Nasdaq
- Market Cap
- KLRS 46.0M
- INTG 38.9M
- IPO Year
- KLRS N/A
- INTG N/A
- Fundamental
- Price
- KLRS $4.78
- INTG $36.30
- Analyst Decision
- KLRS Strong Buy
- INTG
- Analyst Count
- KLRS 3
- INTG 0
- Target Price
- KLRS $21.50
- INTG N/A
- AVG Volume (30 Days)
- KLRS 107.9K
- INTG 17.7K
- Earning Date
- KLRS 11-13-2025
- INTG 11-14-2025
- Dividend Yield
- KLRS N/A
- INTG N/A
- EPS Growth
- KLRS N/A
- INTG N/A
- EPS
- KLRS N/A
- INTG N/A
- Revenue
- KLRS N/A
- INTG $64,378,000.00
- Revenue This Year
- KLRS N/A
- INTG N/A
- Revenue Next Year
- KLRS N/A
- INTG N/A
- P/E Ratio
- KLRS N/A
- INTG N/A
- Revenue Growth
- KLRS N/A
- INTG 10.73
- 52 Week Low
- KLRS $2.14
- INTG $9.57
- 52 Week High
- KLRS $23.69
- INTG $42.50
- Technical
- Relative Strength Index (RSI)
- KLRS 47.17
- INTG 62.61
- Support Level
- KLRS $4.67
- INTG $33.84
- Resistance Level
- KLRS $5.10
- INTG $38.22
- Average True Range (ATR)
- KLRS 0.41
- INTG 4.64
- MACD
- KLRS -0.03
- INTG -0.60
- Stochastic Oscillator
- KLRS 39.41
- INTG 59.71
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About INTG Intergroup Corporation (The)
The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.